TARS logo

Tarsus Pharmaceuticals (TARS) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$94.82 M
-$130.13 M-57.85%

December 31, 2024


Summary


Performance

TARS Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARSbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$94.82 M
-$81.39 M-46.19%

December 31, 2024


Summary


Performance

TARS Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTARSbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

TARS Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-57.9%-46.2%
3 y3 years-44.7%-44.7%
5 y5 years+63.6%+63.6%

TARS Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-57.9%+32.3%-61.4%+43.7%
5 y5-year-57.9%+63.6%-61.4%+78.5%
alltimeall time-57.9%+3926.3%-61.4%+78.5%

Tarsus Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$94.82 M(-57.8%)
$94.82 M(-46.2%)
Sep 2024
-
$176.21 M(-2.7%)
Jun 2024
-
$181.09 M(-6.5%)
Mar 2024
-
$193.71 M(-13.9%)
Dec 2023
$224.95 M(+213.9%)
$224.95 M(-0.8%)
Sep 2023
-
$226.67 M(+112.3%)
Jun 2023
-
$106.77 M(+61.8%)
Mar 2023
-
$66.00 M(-7.9%)
Dec 2022
$71.66 M
$71.66 M(-57.7%)
Sep 2022
-
$169.49 M(-30.9%)
DateAnnualQuarterly
Jun 2022
-
$245.36 M(+40.2%)
Mar 2022
-
$175.01 M(+2.1%)
Dec 2021
$171.33 M(+1.9%)
$171.33 M(-6.8%)
Sep 2021
-
$183.80 M(+4.0%)
Jun 2021
-
$176.74 M(+13.2%)
Mar 2021
-
$156.18 M(-7.1%)
Dec 2020
$168.13 M(+190.1%)
$168.13 M(+94.8%)
Sep 2020
-
$86.33 M(+62.5%)
Jun 2020
-
$53.13 M(-8.3%)
Dec 2019
$57.95 M(+2360.8%)
$57.95 M
Dec 2018
$2.35 M
-

FAQ

  • What is Tarsus Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is Tarsus Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of TARS is $94.82 M

What is the all time high annual cash & cash equivalents for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual cash & cash equivalents is $224.95 M

What is Tarsus Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, TARS annual cash & cash equivalents has changed by -$130.13 M (-57.85%)

What is Tarsus Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of TARS is $94.82 M

What is the all time high quarterly cash and cash equivalents for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly cash and cash equivalents is $245.36 M

What is Tarsus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, TARS quarterly cash and cash equivalents has changed by -$81.39 M (-46.19%)